XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Dec. 31, 2018
Revenue        
Net product sales $ 5,805 $ 5,703 $ 13,396 $ 10,098
Total revenue 5,805 5,703 13,396 10,098
Operating expenses        
Cost of product sales 808 551 1,524 1,051
Research and development 8,781 22,043 17,964 43,287
Selling, general and administrative 8,677 11,323 16,829 23,643
Total operating expenses 18,266 33,917 36,317 67,981
Loss from operations (12,461) (28,214) (22,921) (57,883)
Interest expense (2,470) (2,806) (4,876) (5,535)
Interest income 32 604 222 1,317
Other income—related party 0 0 4,085 0
Other expense (693) 0 (693) 0
Total other income (expense), net (3,131) (2,202) (1,262) (4,218)
Net loss $ (15,592) $ (30,416) $ (24,183) $ (62,101)
Net loss per share, basic and diluted (usd per share) $ (0.57) $ (1.12) $ (0.89) $ (2.29)
Weighted-average common shares outstanding - basic and diluted (in shares) 27,326 27,108 27,282 27,071